Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study

被引:0
|
作者
Mathilde Fraty
Gilberto Velho
Elise Gand
Fréderic Fumeron
Stéphanie Ragot
Philippe Sosner
Kamel Mohammedi
Barnabas Gellen
Pierre-Jean Saulnier
Jean-Michel Halimi
David Montaigne
Grégory Ducrocq
Michaela Rehman
Michel Marre
Ronan Roussel
Samy Hadjadj
机构
[1] CHU de Poitiers,Centre d’Investigation Clinique
[2] CHU de Poitiers,Service d’Endocrinologie
[3] Centre de Recherche des Cordeliers,Diabétologie
[4] Inserm UMR_S 1138,Pole DUNE (Digestif, Urologie, Néphrologie, Endocrinologie)
[5] CHU de Poitiers,Laboratoire MOVE (EA 6314), Faculté des Sciences du Sport
[6] UFR de Médecine,Service de Cardiologie
[7] Université Paris Diderot,Service Néphrologie, Dialyse et Transplantation
[8] Sorbonne Paris Cité,Clinique de Physiologie et Département d’Échocardiographie
[9] UFR de Médecine et Pharmacie,Service de Cardiologie
[10] Université de Poitiers,undefined
[11] CIC 1402,undefined
[12] Inserm Poitiers,undefined
[13] Centre médico-sportif MON STADE,undefined
[14] Centre de Diagnostic et de Thérapeutique,undefined
[15] AP-HP Hôpital Universitaire Hôtel-Dieu,undefined
[16] Université de Poitiers,undefined
[17] Service Endocrinologie,undefined
[18] Diabétologie,undefined
[19] Nutrition,undefined
[20] Hôpital Haut Lévêque,undefined
[21] CHU de Bordeaux,undefined
[22] Polyclinique de Poitiers,undefined
[23] CHU de Tours,undefined
[24] Inserm CIC0202,undefined
[25] CHRU Lille,undefined
[26] Inserm U1011,undefined
[27] EGID,undefined
[28] Institut Pasteur de Lille,undefined
[29] Université de Lille,undefined
[30] Service de Cardiologie,undefined
[31] AP-HP,undefined
[32] Hôpital Bichat Claude Bernard,undefined
[33] CHU de Poitiers,undefined
[34] Service de Diabétologie,undefined
[35] Endocrinologie et Nutrition,undefined
[36] DHU FIRE,undefined
[37] AP-HP,undefined
[38] Hôpital Bichat Claude Bernard,undefined
来源
Diabetologia | 2018年 / 61卷
关键词
Adrenomedullin; Biomarkers; BNP; Heart failure; NT-proBNP; Prognosis; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2643 / 2653
页数:10
相关论文
共 50 条
  • [41] Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I
    Hoffmann, Ursula
    Espeter, Florian
    Weiss, Christel
    Ahmad-Nejad, Parviz
    Lang, Siegfried
    Brueckmann, Martina
    Akin, Ibrahim
    Neumaier, Michael
    Borggrefe, Martin
    Behnes, Michael
    BMC CARDIOVASCULAR DISORDERS, 2015, 15
  • [42] Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I
    Ursula Hoffmann
    Florian Espeter
    Christel Weiß
    Parviz Ahmad-Nejad
    Siegfried Lang
    Martina Brueckmann
    Ibrahim Akin
    Michael Neumaier
    Martin Borggrefe
    Michael Behnes
    BMC Cardiovascular Disorders, 15
  • [43] An integrated multiple marker modality is superior to NT-proBNP alone in prognostic prediction in all-cause mortality in a prospective cohort of elderly heart failure patients
    Holmstrom, A.
    Sigurjonsdottir, R.
    Hammarsten, O.
    Petzold, M.
    Gustafsson, D.
    Fu, M. L. X.
    EUROPEAN GERIATRIC MEDICINE, 2013, 4 (06) : 365 - 371
  • [44] Prognostic significance of tricuspid annular motion and plasma NT-proBNP in patients with heart failure and moderate-to-severe functional mitral regurgitation
    Dini, Frank Lloyd
    Fontanive, Paolo
    Panicucci, Erica
    Andreini, Diana
    Chella, Piersilvio
    De Tommasi, Salvatore Mario
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (06) : 573 - 580
  • [45] Utility of NT-proBNP as an objective marker of postoperative heart failure after coronary artery bypass surgery: a prospective observational study
    Jiang, Huiqi
    Holm, Jonas
    Friberg, Orjan
    Vanky, Farkas
    Vidlund, Marten
    Tajik, Bashir
    Yang, Yanqi
    Svedjeholm, Rolf
    PERIOPERATIVE MEDICINE, 2021, 10 (01)
  • [46] Utility of NT-proBNP as an objective marker of postoperative heart failure after coronary artery bypass surgery: a prospective observational study
    Huiqi Jiang
    Jonas Holm
    Örjan Friberg
    Farkas Vanky
    Mårten Vidlund
    Bashir Tajik
    Yanqi Yang
    Rolf Svedjeholm
    Perioperative Medicine, 10
  • [47] Comparison of Prognostic Value of Red Cell Distribution Width and NT-proBNP for Short-Term Clinical Outcomes in Acute Heart Failure Patients
    He, Wenyan
    Jia, Jun
    Chen, Jia
    Qin, Shu
    Tao, Hongmei
    Kong, Qianran
    Xue, Qiu
    Zhang, Dongying
    INTERNATIONAL HEART JOURNAL, 2014, 55 (01) : 58 - 64
  • [48] Prognostic value of NT-proBNP, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction
    Blanco, Rocio
    Ambrosio, Giuseppe
    Belziti, Cesar
    Lucas, Luciano
    Arias, Anibal
    D'Antonio, Antonella
    Oberti, Pablo
    Carluccio, Erberto
    Pizarro, Rodolfo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 317 : 111 - 120
  • [49] Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial
    Kusunose, Kenya
    Imai, Takumi
    Tanaka, Atsushi
    Dohi, Kaoru
    Shiina, Kazuki
    Yamada, Takahisa
    Kida, Keisuke
    Eguchi, Kazuo
    Teragawa, Hiroki
    Takeishi, Yasuchika
    Ohte, Nobuyuki
    Yamada, Hirotsugu
    Sata, Masataka
    Node, Koichi
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [50] Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus
    Ianos, Raluca Diana
    Iancu, Mihaela
    Pop, Calin
    Lucaciu, Roxana Liana
    Hangan, Adriana Corina
    Rahaian, Rodica
    Cozma, Angela
    Negrean, Vasile
    Mercea, Delia
    Procopciuc, Lucia Maria
    MEDICINA-LITHUANIA, 2024, 60 (11):